Know Cancer

or
forgot password

A Non-interventional Study for Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy. With Special Focus on Patients Who Are in Transition From First Line to Second Line Treatment


N/A
18 Years
N/A
Not Enrolling
Both
Lung Cancer, Non-small Cell Lung Cancer

Thank you

Trial Information

A Non-interventional Study for Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy. With Special Focus on Patients Who Are in Transition From First Line to Second Line Treatment


Inclusion Criteria:



- Patients suffering from non-small cell lung cancer (NSCLC) with clinical stage IIIB
and IV tumours

- Patients with one chemotherapy regimen (first line treatment) (adjuvant chemotherapy
following surgery is also regarded as first line treatment)

- Patients who are in transition from first to second line treatment

- Patients who signed an informed consent

Exclusion Criteria:

- Chemotherapy naïve patients

- Patients ever enrolled in clinical studies treating non-small cell lung cancer
(NSCLC) with chemotherapy (during 1st and 2nd line chemotherapy)

- Patients who ever had chemotherapy for an indication other than NSCLC

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To obtain patient preferences in direct correlation with clinical data from patients suffering from NSCLC stage IIb/IV who are in transition from 1st line to 2nd line treatment

Outcome Time Frame:

once only, 4-6 weeks after switch from 1st to 2nd line chemotherapy

Safety Issue:

No

Principal Investigator

Christopher Teale

Investigator Role:

Study Director

Investigator Affiliation:

AstraZeneca UK Limited, Alderley House, Alderley Park, Macclesfield SK10 4TF, Cheshire, United Kingdom, Phone: +44 1625 516549 Fax: +44 1625 518982

Authority:

Germany: Federal Institute for Drugs and Medical Devices

Study ID:

NIS-ODE-DUM-2008/1

NCT ID:

NCT00721981

Start Date:

April 2009

Completion Date:

October 2009

Related Keywords:

  • Lung Cancer
  • Non-Small Cell Lung Cancer
  • patient preference
  • oncology
  • chemotherapy
  • NSCLC
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Stress, Psychological

Name

Location